189 related articles for article (PubMed ID: 52720)
1. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
Osteen RT; Piessens WF; David JR; Churchill WH
J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
[TBL] [Abstract][Full Text] [Related]
2. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of guinea-pig lymphoid cells against guinea-pig hepatoma cells in tissue culture.
Andjargholi M; Dale MM
Br J Cancer; 1977 Jan; 35(1):59-67. PubMed ID: 188438
[TBL] [Abstract][Full Text] [Related]
4. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.
Churchill WH; Piessens WF; Sulis CA; David JR
J Immunol; 1975 Sep; 115(3):781-6. PubMed ID: 50373
[TBL] [Abstract][Full Text] [Related]
5. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
Zwilling BS; Leonard EJ; Bast RC; Zbar B
J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
[No Abstract] [Full Text] [Related]
6. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
Borsos T; Rapp HJ
J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
[No Abstract] [Full Text] [Related]
7. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
Rella W; Chaput B
Oncology; 1978; 35(3):136-42. PubMed ID: 209379
[TBL] [Abstract][Full Text] [Related]
8. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody.
Smith HG; Meltzer MS; Leonard EJ
J Natl Cancer Inst; 1976 Oct; 57(4):809-13. PubMed ID: 187778
[TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxicity of tumorigenic and nontumorigenic strain-2 guinea pig cells as mediated by syngeneic phytohemagglutinin-stimulated peritoneal exudate cells.
Zwilling BS; Meltzer MS; Evans CH
J Natl Cancer Inst; 1975 Mar; 54(3):743-7. PubMed ID: 1091742
[TBL] [Abstract][Full Text] [Related]
11. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
Bucana C; Hanna MG
J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
[No Abstract] [Full Text] [Related]
12. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
13. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
Abe S; Berczi I; Sehon AH
Int J Cancer; 1977 Oct; 20(4):595-606. PubMed ID: 199549
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
[No Abstract] [Full Text] [Related]
15. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
Minden P; McClatchy JK; Wainberg M; Weiss DW
J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
[No Abstract] [Full Text] [Related]
16. Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.
Paque RE; Meltzer MS; Zbar B; Rapp HJ; Dray S
Cancer Res; 1973 Dec; 33(12):3165-71. PubMed ID: 4357351
[No Abstract] [Full Text] [Related]
17. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
18. Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.
Embleton MJ
Br J Cancer; 1976 Jun; 33(6):584-92. PubMed ID: 181041
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
Wainberg MA; Deutsch V; Weiss DW
Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
[TBL] [Abstract][Full Text] [Related]
20. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
Churchill WH; Zbar B; Belli JA; David JR
J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
